Investors Land XENE Even Cheaper Than Its Secondary Stock Offering

Looking back to 106 days ago, Xenon Pharmaceuticals Inc (XENE) priced a 8,474,577 share secondary stock offering at $29.50 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.